Benitec Biopharma BNTC
NASDAQ BNTC
$12.76 +0.32 (+2.57%)
As of: Sep 4, 2026 · 3:12 PM EDT

Benitec Biopharma (BNTC) EPS (Diluted) (2021 - 2025)

Analysis

Benitec Biopharma (BNTC) EPS (Diluted) (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 12.23
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 7.15
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.02 Bn 44.02 Bn - -3.06
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.43 Bn 27.59 Bn - 0.15
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -0.06
10 Benitec Biopharma 586.58 Mn 586.58 Mn - -0.26
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.26
Sep 30, 2025 -0.22
Jun 30, 2025 -0.45
Mar 31, 2025 -0.24
Dec 31, 2024 -0.43
Sep 30, 2024 -0.48
Jun 30, 2024 -1.16
Mar 31, 2024 -1.64
Dec 31, 2023 -2.64
Sep 30, 2023 -3.05
Jun 30, 2023 -3.29
Mar 31, 2023 -2.64
Dec 31, 2022 -3.47
Sep 30, 2022 -7.19
Jun 30, 2022 -9.88
Mar 31, 2022 -7.22
Dec 31, 2021 -10.08
Sep 30, 2021 -10.03
Jun 30, 2021 -15.26